Assuming 25% QoQ increase from the analytical division:
2017 CY forecast would give us around $1.2M
Add another $166k from PromarkerD DR royalties so we land at around $1.4M.
General Opex for R&D/staff/admin/marketing etc is around $3.5M (assuming cost stay as reported in Q1)
If R&D stays at around $450k the tax rebate will be around $780k so adding that to our $1.4M will see us around $2.2M potential close of CY 2018.Hopefully the on-going investments into R&D will pay off soon enough, if we land more PromarkerD sales this year that would be fantastic and hopefully analytical service continues to see growth.
PIQ Price at posting:
21.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)